PDE3/PDE4 drugs for Chronic Obstructive Pulmonary Disease

4 tracked PDE3/PDE4 drugs in the Chronic Obstructive Pulmonary Disease race. The class explanation lives on the PDE3/PDE4 page; the full indication pipeline across every mechanism is on the Chronic Obstructive Pulmonary Disease page.

1 approved / phase 41 Phase 31 Phase 21 Phase 1/2

Head-to-head evidence: HRS-9821 vs KIT2014 · HRS-9821 vs TQC3721 · ensifentrine vs HRS-9821 · KIT2014 vs TQC3721 · ensifentrine vs KIT2014 · ensifentrine vs TQC3721

The roster

← all PDE3/PDE4 drugs